Galway-based Chanelle Pharma has announced that Angelo Gatto has been appointed as Chief Executive Officer with immediate effect.
Founded in 1985 by Michael Burke, Chanelle employs more than 700 people at sites in Ireland, the UK, Portugal and Jordan.
In February of this year Burke sold the manufacturer of generic pharmaceuticals to Exponent, a private equity firm. Reports at the time put the value of the deal in the region of €300m.
ADVERTISEMENT
Gatto, who previously worked at several major multinational pharmaceutical companies played an advisory role for Exponent at the time of its investment in Chanelle. The company said he is joining the firm to “lead the next phase of growth."
Chairman of Chanelle, Carsten Hellman said: “Angelo brings relevant experience in all our business areas, and has demonstrated remarkable excellence throughout his entire career. I am confident in his ability to lead Chanelle Pharma through this exciting next chapter."
Gatto said that he is looking forward to working closely with the team at Chanelle to develop the company’s emerging product pipeline.
He cited Chanelle’s unique position in focusing on both human and animal health.
Register for free to read this story and our free stories.
This content is available to digital subscribers and loyalty code users only. Sign in to your account, use the code or subscribe to get unlimited access.
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
CODE ACCEPTED
You have full access to the site until next Wednesday at 9pm.
CODE NOT VALID
Please try again or contact support.
Galway-based Chanelle Pharma has announced that Angelo Gatto has been appointed as Chief Executive Officer with immediate effect.
Founded in 1985 by Michael Burke, Chanelle employs more than 700 people at sites in Ireland, the UK, Portugal and Jordan.
In February of this year Burke sold the manufacturer of generic pharmaceuticals to Exponent, a private equity firm. Reports at the time put the value of the deal in the region of €300m.
Gatto, who previously worked at several major multinational pharmaceutical companies played an advisory role for Exponent at the time of its investment in Chanelle. The company said he is joining the firm to “lead the next phase of growth."
Chairman of Chanelle, Carsten Hellman said: “Angelo brings relevant experience in all our business areas, and has demonstrated remarkable excellence throughout his entire career. I am confident in his ability to lead Chanelle Pharma through this exciting next chapter."
Gatto said that he is looking forward to working closely with the team at Chanelle to develop the company’s emerging product pipeline.
He cited Chanelle’s unique position in focusing on both human and animal health.
If you would like to speak to a member of our team, please call us on 01-4199525.
Link sent to your email address
We have sent an email to your address. Please click on the link in this email to reset your password. If you can't find it in your inbox, please check your spam folder. If you can't find the email, please call us on 01-4199525.
ENTER YOUR LOYALTY CODE:
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
SHARING OPTIONS